Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 3 | 2024 | 478 | 1.560 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2024 | 93 | 0.860 |
Why?
|
| Workload | 1 | 2024 | 200 | 0.820 |
Why?
|
| Critical Care | 3 | 2024 | 803 | 0.810 |
Why?
|
| Hospitalists | 1 | 2022 | 59 | 0.750 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 89 | 0.740 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2021 | 80 | 0.730 |
Why?
|
| Apnea | 1 | 2020 | 36 | 0.720 |
Why?
|
| Leishmania | 3 | 2009 | 34 | 0.700 |
Why?
|
| Brain Death | 1 | 2020 | 59 | 0.700 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 365 | 0.650 |
Why?
|
| Stroke | 1 | 2023 | 1061 | 0.480 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2014 | 49 | 0.460 |
Why?
|
| Brain Edema | 1 | 2014 | 96 | 0.450 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 114 | 0.450 |
Why?
|
| Acrocephalosyndactylia | 1 | 2013 | 23 | 0.420 |
Why?
|
| Pediatrics | 1 | 2022 | 1187 | 0.420 |
Why?
|
| Leishmaniasis, Visceral | 2 | 2009 | 24 | 0.400 |
Why?
|
| Hydrocephalus | 1 | 2014 | 260 | 0.390 |
Why?
|
| Cerebellum | 1 | 2014 | 471 | 0.360 |
Why?
|
| Child | 9 | 2024 | 30496 | 0.260 |
Why?
|
| Macrophages | 2 | 2012 | 1351 | 0.260 |
Why?
|
| Hypertension | 1 | 2014 | 1596 | 0.240 |
Why?
|
| United States | 3 | 2024 | 15856 | 0.190 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2021 | 131 | 0.180 |
Why?
|
| World Health Organization | 1 | 2021 | 327 | 0.180 |
Why?
|
| Neurologic Examination | 1 | 2020 | 263 | 0.170 |
Why?
|
| Delirium | 1 | 2021 | 210 | 0.160 |
Why?
|
| Tracheal Stenosis | 1 | 2019 | 42 | 0.160 |
Why?
|
| Laryngostenosis | 1 | 2019 | 37 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 4136 | 0.160 |
Why?
|
| Infant | 4 | 2023 | 13939 | 0.160 |
Why?
|
| Humans | 18 | 2024 | 270457 | 0.150 |
Why?
|
| Hospital Mortality | 1 | 2023 | 1233 | 0.140 |
Why?
|
| NADPH Oxidase 1 | 1 | 2016 | 7 | 0.140 |
Why?
|
| Informed Consent | 1 | 2020 | 415 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2019 | 481 | 0.140 |
Why?
|
| Superoxides | 1 | 2016 | 219 | 0.130 |
Why?
|
| Critical Illness | 1 | 2021 | 739 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 158 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 3944 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 183 | 0.130 |
Why?
|
| Fatal Outcome | 2 | 2018 | 824 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2019 | 728 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 875 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8626 | 0.120 |
Why?
|
| Fourth Ventricle | 1 | 2014 | 50 | 0.120 |
Why?
|
| Brazil | 3 | 2009 | 170 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 4480 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 717 | 0.110 |
Why?
|
| Parents | 1 | 2020 | 1080 | 0.110 |
Why?
|
| Leishmania guyanensis | 1 | 2012 | 4 | 0.110 |
Why?
|
| Hospitalization | 1 | 2022 | 2163 | 0.100 |
Why?
|
| Drainage | 1 | 2014 | 462 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5921 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 433 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 1586 | 0.090 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2007 | 109 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 304 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2023 | 16999 | 0.090 |
Why?
|
| Adolescent | 4 | 2021 | 32671 | 0.080 |
Why?
|
| Interleukin-1alpha | 1 | 2008 | 54 | 0.080 |
Why?
|
| Leishmania infantum | 1 | 2007 | 7 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 7784 | 0.070 |
Why?
|
| Leishmaniasis | 1 | 2007 | 33 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2007 | 156 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 628 | 0.070 |
Why?
|
| Genotype | 2 | 2013 | 4251 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 295 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2007 | 232 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2007 | 276 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 583 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2016 | 2928 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2008 | 484 | 0.060 |
Why?
|
| Phenotype | 3 | 2013 | 6497 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2013 | 1695 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2008 | 1182 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2008 | 1051 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2023 | 39751 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 4822 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2007 | 700 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 2473 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 3607 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 5142 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2008 | 5690 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 219 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 7014 | 0.040 |
Why?
|
| Analgesics | 1 | 2021 | 409 | 0.040 |
Why?
|
| Male | 7 | 2019 | 128105 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 7273 | 0.040 |
Why?
|
| Airway Extubation | 1 | 2019 | 74 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7897 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2016 | 74 | 0.030 |
Why?
|
| Animals | 4 | 2009 | 62021 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2016 | 43 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 73175 | 0.030 |
Why?
|
| Indans | 1 | 2016 | 70 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 124 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 233 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 279 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 269 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 303 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 4648 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2019 | 6204 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 1997 | 344 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 1997 | 481 | 0.030 |
Why?
|
| Mutation | 1 | 2013 | 15908 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 1462 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 2002 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 397 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2197 | 0.020 |
Why?
|
| Female | 5 | 2019 | 148644 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 1562 | 0.020 |
Why?
|
| Young Adult | 1 | 2008 | 22152 | 0.020 |
Why?
|
| Biopsy | 1 | 1997 | 3387 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 5339 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 4947 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2007 | 69 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2007 | 604 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2007 | 876 | 0.020 |
Why?
|
| Adult | 2 | 2008 | 81754 | 0.010 |
Why?
|
| Middle Aged | 2 | 2008 | 90100 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 6394 | 0.010 |
Why?
|
| Computational Biology | 1 | 2007 | 1292 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 2591 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 3441 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 12991 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 12104 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 464 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 5774 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 5159 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 6188 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 30936 | 0.000 |
Why?
|